Rhythma Kaul reports:
After reports of a data leak from Hyderabad-based global pharmaceutical company Dr Reddy’s Laboratories Ltd, one of country’s leading pathology laboratory chains came out, IT has been forced to temporarily shut operations in its plants across the world.
[…]
Dr Reddy’s Laboratories had recently received approval from the drugs controller general of India to conduct an adaptive phase 2/3 clinical trial in India for Russia’s Sputnik V vaccine candidate against Coronavirus disease (Covid-19).
Read more on Hindustan Times.